107 related articles for article (PubMed ID: 22129489)
1. Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montréal Heart Institute.
Potter BJ; White M; Carrier M; Pellerin M; L'Allier PL; Pelletier GB; Racine N; Ducharme A
Can J Cardiol; 2012; 28(1):69-73. PubMed ID: 22129489
[TBL] [Abstract][Full Text] [Related]
2. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
4. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
6. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy.
Bhatia S; Frantz RP; Severson CJ; Durst LA; McGoon MD
Mayo Clin Proc; 2003 Oct; 78(10):1207-13. PubMed ID: 14531479
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy.
Tay EL; Papaphylactou M; Diller GP; Alonso-Gonzalez R; Inuzuka R; Giannakoulas G; Harries C; Wort SJ; Swan L; Dimopoulos K; Gatzoulis MA
Int J Cardiol; 2011 Jun; 149(3):372-6. PubMed ID: 20304507
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
Barst RJ; Ivy DD; Gaitan G; Szatmari A; Rudzinski A; Garcia AE; Sastry BK; Pulido T; Layton GR; Serdarevic-Pehar M; Wessel DL
Circulation; 2012 Jan; 125(2):324-34. PubMed ID: 22128226
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M
J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754
[TBL] [Abstract][Full Text] [Related]
13. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
14. Pattern of resolution of pulmonary hypertension, long-term allograft right ventricular function, and exercise capacity in high-risk heart transplant recipients listed under oral sildenafil.
De Santo LS; Buonocore M; Agrusta F; Bancone C; Galdieri N; Romano G; Maiello C; Amarelli C
Clin Transplant; 2014 Jul; 28(7):837-43. PubMed ID: 24828060
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil in Heart failure (SilHF). An investigator-initiated multinational randomized controlled clinical trial: rationale and design.
Cooper TJ; Guazzi M; Al-Mohammad A; Amir O; Bengal T; Cleland JG; Dickstein K
Eur J Heart Fail; 2013 Jan; 15(1):119-22. PubMed ID: 23097067
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
[TBL] [Abstract][Full Text] [Related]
17. Sustained improvement of clinical status and pulmonary hypertension in patients with severe heart failure treated with sildenafil.
Urbanowicz T; Straburzyńska-Migaj E; Katyńska I; Araszkiewicz A; Oko-Sarnowska Z; Grajek S; Jemielity M
Ann Transplant; 2014 Jul; 19():325-30. PubMed ID: 25007352
[TBL] [Abstract][Full Text] [Related]
18. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
Kothari SS; Duggal B
Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
[TBL] [Abstract][Full Text] [Related]
19. Six months of Sildenafil therapy improves heart rate recovery in patients with heart failure.
Guazzi M; Arena R; Pinkstaff S; Guazzi MD
Int J Cardiol; 2009 Aug; 136(3):341-3. PubMed ID: 18667251
[TBL] [Abstract][Full Text] [Related]
20. The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study.
Reichenbach A; Al-Hiti H; Malek I; Pirk J; Goncalvesova E; Kautzner J; Melenovsky V
Int J Cardiol; 2013 Sep; 168(1):60-5. PubMed ID: 23058346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
